Bladder Cancer - Results from #120

Adjuvant Radiotherapy After Radical Cystectomy for Muscle-invasive Bladder Cancer: A Phase 2 Trial-Results of Secondary Endpoints. February 21, 2025

Sarcomatoid areas of urothelial carcinoma are enriched for CD163-positive antigen-presenting cells. February 21, 2025

Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial. February 21, 2025

UroGen Advances Long-Term Growth Strategy by Acquiring a Next-Generation Investigational Oncolytic Virus (ICVB-1042) and Announces Multiple Strategic Research Collaborations February 20, 2025

Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancer. February 20, 2025

Evaluating biparametric MRI for diagnosing muscle-invasive bladder cancer with variant urothelial histology: a multicenter study. February 20, 2025

FDA Authorizes ImmunityBio to Provide Recombinant BCG (rBCG) to Urologists to Address TICE® BCG Shortage February 19, 2025

The impact of a multidisciplinary approach on treatment decisions and outcomes in urothelial carcinoma: A systematic review. February 19, 2025

Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease. February 19, 2025

News on Richard Wolf/Photocure Collaboration: Interim Flexible BLC Solution Available in Countries Where System Blue and Richard Wolf Reusable Flexible Cystoscopes Are Cleared February 18, 2025

The oncological impact of complete transurethral resection before neoadjuvant chemotherapy in muscle-invasive bladder cancer. February 18, 2025

Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposure. February 18, 2025

Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients With Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. February 16, 2025

Circulating tumor DNA in muscle-invasive bladder cancer: A systematic review. February 16, 2025

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Nationwide Analysis of Eligibility, Utilization, and Outcomes. February 14, 2025

Oncological outcomes of patients with node positive disease following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: A multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma wor February 14, 2025

Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European study. February 13, 2025

Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical Cystectomy. February 13, 2025

Machine Learning Accurately Predicts Muscle Invasion of Bladder Cancer Based on Three miRNAs. February 12, 2025

Gemcitabine versus Bacillus Calmette-Guerin for Intravesical Therapy in Treatment-Naïve Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer. February 12, 2025

Page 7 of 535